Plasmodium falciparum Glutamate-rich protein R0 region (GLURP R0)

The Plasmodium falciparum Glutamate-rich protein (GLURP) R0 region is a highly conserved N-terminal domain of the GLURP protein, which is expressed during both the pre-erythrocytic and erythrocytic stages of the malaria parasite's life cycle [3, 6]. Located on the surface of merozoites and infected erythrocytes, the R0 region (spanning amino acids 27-500) serves as a critical target for naturally acquired protective immunity in humans living in malaria-endemic regions [1, 4]. Antibodies directed against this region, specifically cytophilic IgG1 and IgG3, do not typically block merozoite invasion directly but instead mediate parasite killing through antibody-dependent cellular inhibition (ADCI) in cooperation with monocytes [1, 11, 14]. Due to its relative conservation and strong immunogenicity, the R0 region is a primary component of several malaria vaccine candidates, most notably the GMZ2 fusion protein, which combines GLURP R0 with the C-terminal part of Merozoite Surface Protein 3 (MSP3) [6, 8, 10]. Clinical trials have demonstrated that vaccines targeting this region can induce functional antibodies that correlate with reduced parasite density and protection against clinical malaria, although achieving high efficacy remains a significant therapeutic challenge [2, 5, 13].

Other names

N-terminal non-repetitive region of GLURPGLURP-R0GLURP(27-500)PF3D7_1035300 R0 region

Induction of antibody-dependent cellular inhibition (ADCI)